About
OUR STORY
Rethinking skin health through regenerative science.
The Story Behind LevEllis
“The world doesn't need another skincare product.”
That was Dr. Laura Ellis' first thought when she met stem-cell scientist Dr. Hans Keirstead.
But what began as skepticism became a conversation that would change the course of her career.
A Different Kind of Discovery
A discovery born of serendipity.
While conducting cancer research, stem-cell scientist Dr. Hans Keirstead made an unexpected discovery: the complete skin-specific secretome produced by human skin progenitor cells.
Rather than an isolated ingredient, this complex biological environment brings together growth factors, extracellular vesicles, and other signaling molecules—including fetuin-A—revealing a different approach to skin biology.
When Dr. Keirstead introduced the technology to Dr. Ellis
her scientific curiosity led her to explore its potential in clinical practice.
From Science to Practice
Where discovery met clinical experience.
As a surgeon and physician with a background in molecular biology, Dr. Ellis understood the importance of evaluating new science through the lens of clinical practice.
She began exploring the technology in her practice, alongside the aesthetic treatments she already offered. Over time, that experience reshaped her perspective on what regenerative skin science could make possible.
From Discovery to Conviction
“What I saw changed how I practice medicine.”
Laura Ellis, MD — Surgeon, Molecular Biologist, Founder & CEO, LevEllis
From Conviction to Purpose
From one practice to a greater purpose.
After nearly three decades in medicine, Dr. Ellis made the decision to leave her practice—not to leave her mission behind, but to pursue it on a much larger scale.
She founded LevEllis to bring this technology beyond the walls of her practice. In 2025, that vision took its first commercial form with the launch of PROVOQUE™ Facial Serum—bringing complete, skin-specific regenerative science to professional skin health.
PROVOQUE™ Facial Serum · Launched 2025
Our Purpose
This is only the beginning.
PROVOQUE is the first expression of LevEllis' tissue-specific cell signaling platform—with a vision that extends beyond aesthetics.
Executive Leadership
Laura Ellis, MD
Founder & CEO
Shannon Crothers
Chief Operating Officer
Renee Romero Pedroza
Chief Marketing Officer
Wendy Patrick
Vice President of Sales
Scientific Advisory Board
LevEllis' regenerative platform is guided by a multidisciplinary Scientific Advisory Board spanning stem-cell biology, regenerative medicine, translational science, biologics development, and clinical aesthetics—bringing expertise from foundational discovery through clinical application.
Hans S. Keirstead, PhD
Technology Inventor
CEO, AIVITA Biomedical
Dr. Hans Keirstead is a stem-cell scientist and biotechnology executive with more than three decades of experience in regenerative medicine. As CEO of AIVITA Biomedical and inventor of the skin-specific secretome technology behind PROVOQUE, his work connects foundational cell biology with translational biotechnology. His scientific career includes extensive research, publications, patents, and leadership in stem-cell research.
Jordan R. Plews, PhD
Stem-Cell Biologist
Regenerative Aesthetics Pioneer
Dr. Jordan R. Plews is a stem-cell biologist and regenerative aesthetics pioneer whose work bridges stem-cell science, cell-derived signaling, and the development of regenerative technologies. His expertise brings a translational perspective to the application of regenerative biology in professional aesthetics.
Gabriel Nistor, MD
Chief Science Officer
AIVITA Biomedical
Dr. Gabriel Nistor is a physician-scientist with expertise in stem-cell research, regenerative medicine, and translational development. As Chief Science Officer at AIVITA Biomedical, he brings experience advancing cell-based technologies from scientific research toward clinical investigation and application.
Julie Ann Woodward, MD
Division Chief, Oculofacial Surgery
Professor, Duke University
Dr. Julie Ann Woodward is an oculofacial plastic surgeon and academic physician at Duke University, with expertise in oculofacial surgery, aesthetic medicine, and clinical skin health. Her clinical and academic perspective helps connect regenerative science with the needs of physicians and patients.
Our Principles
The principles behind our progress.
01
Scientific curiosity
We challenge conventional thinking and follow the biology wherever discovery leads.
02
Clinical conviction
We believe meaningful innovation must be informed by the physicians, providers, and patients it serves.
03
Responsible advancement
We are committed to scientific integrity, thoughtful development, and advancing the understanding of regenerative skin health.